Resources/
Phil Blog
Phil Blog
Meet Chris Sweitzer, VP of Business Development at PHIL
In this employee spotlight interview, we are excited to feature Chris Sweitzer, our new Vice President of Business Development at PHIL. With two decades of experience in the healthcare industry and a passion for enhancing patient access, Chris brings a wealth of knowledge and a unique perspective to our team. Please tell us a little bit about yourself and your role at PHIL
Integrating Telemedicine Into Your Pharmaceutical Brand’s DTC Strategy
The popularity of direct-to-consumer (DTC) channels across industries has fueled patients’ expectations for convenience, cost savings, and improved access to healthcare services. While the COVID-19 pandemic cemented the idea that telemedicine can be a critical part of a pharmaceutical brand’s go-to-market strategy, it’s essential to recognize that it is just one piece of the puzzle. To truly transform the patient experience and improve brand outcomes, pharmaceutical brand teams need to integrate a telemedicine channel within a broader DTC strategy
Meet Jwalanta Shrestha, Director of Engineering, Data and Infrastructure, at Phil
We recently caught up with Jwalanta Shrestha, our Director of Engineering, Data and Infrastructure, to get a behind-the-scenes look at his role in ensuring patients and our manufacturer partners have the right data when they need it. Please tell us about your time with Phil and your current Director of Engineering, Data, and Infrastructure role. I currently lead two different teams at Phil
8 Strategies to Decrease Prescription Abandonment and Improve Medication Adherence
An estimated 1 in 5 prescriptions are left at the pharmacy counter. This vexing healthcare challenge, known as prescription abandonment, is part of the broader concern of medication non-adherence, which also includes not taking medications as prescribed or failing to refill prescriptions. The issue is so prevalent that the American Medical Association (AMA) advises healthcare providers to "consider medication non-adherence first as a reason a patient's condition is not under control." Consequences of Prescription Abandonment Failure to stick with prescribed therapy is a substantial obstacle to a providers’ ability to deliver good patient outcomes and realize the value of pharmaceutical innovation
Meet Andrew Duncan, SVP of Business Operations, Pricing, and Strategic Finance at Phil
We recently caught up with Andrew Duncan, our SVP of Business Operations, Pricing, and Strategic Finance. Andrew shares how his personal connection with Phil’s mission is what he likes most about his role and a recent success that he is particularly proud of. Please tell us a little bit about yourself and your role at Phil
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
Create a Path to Commercial Success
Our expert team can build a tailored access program that drives your brand goals.
Our Solution
About Us
